Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin

Management of chemotherapy-induced peripheral neuropathy (CIPN) remains a significant challenge in the treatment of cancer. Risk mitigation for CIPN involves preemptive reduction of cumulative dose or reduction of dose intensity upon emergence of symptoms, despite the risk of reduced tumor efficacy....

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, B. L., Cho, E., Honigberg, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481642/
https://www.ncbi.nlm.nih.gov/pubmed/36114333
http://dx.doi.org/10.1038/s41598-022-18716-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481642/
https://www.ncbi.nlm.nih.gov/pubmed/36114333
http://dx.doi.org/10.1038/s41598-022-18716-5

Ejemplares similares